Judge rejects two separate drug mergers

Article Abstract:

A separate pair of proposed mergers in which the McKesson Corp. had agreed to acquire the American Health Corp. for $1.72 billion and Cardinal Health Inc. had agreed to acquire Bergen Brunswig Corp. for $2.41 billion has been rejected by a US District Court judge in Washington. The court, siding with the Federal Trade Commission, ruled that both mergers would violate Federal antitrust laws. The merger would have allowed the two combined companies to dominate the $64 billion domestic drug market by giving them a 67% market share.

Comment:

Proposed agreement to acquire American Health Corp. for $1.72 bil rejected by Federal court

Hospitals, Company Planning/Goals, Drugs and Druggists' Sundries Wholesalers, Drugs, Cosmetics, Toiletries Whsle, Bergen Brunswig Corp., Cardinal Health Inc., Article, American Healthcorp Inc., McKesson Drug Co.

---

Medtronic set to buy Arterial for $3.7 billion

Article Abstract:

Pacemaker and other medical devices maker Medtronic Inc. will add stents to its product list by acquiring Santa Rosa, Calif.-based Arterial Vascular Engineering Inc. for $3.7 billion in stock. Analysts wonder whether this acquisition added to November's announcement to acquire the Sofamor Danek Group will be too much too soon.

Medical Instruments and Supplies, Medical Equipment and Supplies Manufacturing, Medical Instruments & Supplies, Mergers, acquisitions and divestments, Abstract, Medical equipment, Medical equipment industry, Medtronic Inc., MDT, Arterial Vascular Engineering Inc.

---

Similar abstracts:

• Abstracts: ARCO expected to sell unit to Lyondell. AIG to buy SunAmerica for $1.8 billion
• Abstracts: Radio concern Chancellor Media agrees to buy Martin Media for $610 million. part 2 Chancellor is set to purchase 50% of Radio Centro
• Abstracts: Cendant's board agrees to overhaul top options deals. Cendant ends pact to buy American Bankers
• Abstracts: Drug giants agree to settle pricing suit. Zeneca sues Eli Lilly over Evista promotion. Lilly, in coup, settles for only $4 million portion of patent challenge to Prozac
• Abstracts: Marsh & McLennan will buy Sedgwick. TRW to buy Lucas Varity for $7 billion

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.